STOCK TITAN

Carmell Stock Price, News & Analysis

CTCX NASDAQ

Company Description

Overview of Carmell Corp (CTCX)

Carmell Corp is a specialized bio-aesthetics company that has carved its niche by leveraging its proprietary Carmell Secretome technology to enhance skin and hair health along with developing advanced solutions for bone and tissue healing. Utilizing a potent blend of growth factors and proteins extracted from allogeneic human platelets sourced from U.S. FDA‐approved tissue banks, the company has developed a portfolio of cosmetic skincare products and a pipeline of innovative formulas. This includes products like the signature Carmell G.L.E.E and several next-generation formulations such as youth restoring, ultra-brightening, ultra-hydrating, and rapid recovery treatments. The incorporation of strategic industry-specific ingredients in their formulations underscores Carmell Corp's commitment to addressing both cosmetic and therapeutic demands in a sophisticated and scientifically driven manner.

Innovative Technology and Product Formulation

Central to Carmell Corp's product excellence is the Carmell Secretome, a breakthrough formulation that integrates a powerful cocktail of growth factors and proteins to support skin rejuvenation and hair vitality. Complementing this is the company’s proprietary microemulsion technology, engineered to efficiently deliver both lipophilic and hydrophilic active ingredients without resorting to commonly used excipients known as the "Foul Fourteen." This approach not only enhances product performance by avoiding mineral and vegetable oils but also ensures a non-comedogenic profile ideal for professional-grade skincare treatments.

Business Model and Market Position

Carmell Corp operates through a single focused business segment: the development and commercialization of advanced bio-aesthetics products. The firm targets both professional care providers and discerning retail customers who demand scientifically validated cosmetic and therapeutic solutions. By balancing clinical insight with innovative formulation technologies, the company generates value through the rigorous testing and refinement of its bio-active compounds, positioning itself as a key player in the cosmetic skincare and tissue healing markets. This focused approach allows Carmell Corp to maintain expertise in its core areas and ensures that its products meet the high technical requirements of today’s professional and consumer markets.

Scientific Expertise and Industry Insights

The company’s emphasis on research-driven product development has enabled it to address complex cosmetic and dermatological challenges. The integration of bio-active compounds with a carefully engineered microemulsion system showcases Carmell Corp’s commitment to leveraging advanced biotechnology in everyday skincare applications. Furthermore, the pipeline includes innovative formulas aimed at specific aesthetic and therapeutic benefits, reflecting the company's deep understanding of skin physiology and tissue repair mechanisms. Such scientific rigor and technical innovation cement Carmell Corp's position as a trusted name in the bio-aesthetics space.

Product Portfolio and Technological Excellence

In addition to its core cosmetic skincare product, Carmell Corp is diversifying its offerings with the development of an exclusive men’s product line and specialized topical haircare treatments. These products are designed to meet a wide array of consumer needs, guided by rigorous research and advanced formulation science. Each product is developed with an eye on both efficacy and safety, ensuring that the active ingredients are delivered in a manner that optimizes their biological activity while minimizing potential irritants. This holistic approach to product development signifies Carmell Corp's ethos of merging cutting-edge science with practical, high-performance solutions.

Position within the Competitive Landscape

In a competitive industry marked by rapid technological advancements and ever-evolving consumer demands, Carmell Corp distinguishes itself through its unique blend of biotechnology and formulation innovation. The company’s strategic emphasis on eliminating common excipients in favor of a cleaner, targeted delivery mechanism creates a distinct competitive advantage. Market participants and industry analysts frequently note the company’s commitment to safety and scientific validation as critical differentiators. By consistently prioritizing research and development, Carmell Corp reinforces its authority in an industry where technological precision and a commitment to quality are paramount.

Conclusion

Overall, Carmell Corp stands out as a bio-aesthetics innovator that fuses sophisticated technological processes with practical applications in cosmetic skincare and tissue healing. Its proprietary technology, combined with a robust product development strategy, positions the company as a significant participant in the evolving landscape of aesthetic and therapeutic care. The emphasis on safety, efficacy, and scientific validation not only meets the stringent needs of professional care providers but also ensures a trusted reputation among consumers seeking advanced bio-active solutions.

Stock Performance

$—
0.00%
0.00
Last updated:
-93.45 %
Performance 1 year
$5.9M
Market Cap
30.1M
Shares outstanding

SEC Filings

No SEC filings available for Carmell.

Financial Highlights

$20,519
Revenue (TTM)
-$2,878,481
Net Income (TTM)
-$0.14
Diluted EPS (TTM)
-$1,402,631
Operating Cash Flow
-14,028.37%
Net Profit Margin
-6,919.39%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Carmell (CTCX)?

The current stock price of Carmell (CTCX) is $0.1973 as of March 10, 2025.

What is the market cap of Carmell (CTCX)?

The market cap of Carmell (CTCX) is approximately 5.9M.

What is the revenue (TTM) of Carmell (CTCX) stock?

The trailing twelve months (TTM) revenue of Carmell (CTCX) is $20,519.

What is the net income of Carmell (CTCX)?

The trailing twelve months (TTM) net income of Carmell (CTCX) is -$2,878,481.

What is the earnings per share (EPS) of Carmell (CTCX)?

The diluted earnings per share (EPS) of Carmell (CTCX) is -$0.14 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Carmell (CTCX)?

The operating cash flow of Carmell (CTCX) is -$1,402,631.

What is the profit margin of Carmell (CTCX)?

The net profit margin of Carmell (CTCX) is -14,028.37%.

What is the operating margin of Carmell (CTCX)?

The operating profit margin of Carmell (CTCX) is -6,919.39%.

What is the gross margin of Carmell (CTCX)?

The gross profit margin of Carmell (CTCX) is 76.41%.

What is the current ratio of Carmell (CTCX)?

The current ratio of Carmell (CTCX) is 0.31, indicating the company's ability to pay short-term obligations.

What is the gross profit of Carmell (CTCX)?

The gross profit of Carmell (CTCX) is $15,679 on a trailing twelve months (TTM) basis.

What is the operating income of Carmell (CTCX)?

The operating income of Carmell (CTCX) is -$1,419,789.

What is the Carmell Secretome?

The Carmell Secretome is a proprietary formulation that utilizes a blend of growth factors and proteins extracted from allogeneic human platelets to support skin and hair health.

What products does Carmell Corp offer?

Carmell Corp offers a portfolio of cosmetic skincare products, including its flagship Carmell G.L.E.E, and is developing additional formulations like youth restoring, ultra-brightening, ultra-hydrating, and rapid recovery treatments. They are also expanding into men’s skincare and topical haircare products.

How does Carmell Corp differentiate its product formulations?

The company uses a novel microemulsion technology that delivers both lipophilic and hydrophilic ingredients efficiently without relying on commonly used excipients, ensuring non-comedogenic and high-performance products.

Who are the target customers of Carmell Corp?

Carmell Corp targets both professional care providers and discerning retail consumers who demand scientifically validated and advanced cosmetic and tissue healing solutions.

What is the main focus of Carmell Corp's business model?

The company is solely focused on the development and commercialization of bio-aesthetics solutions—integrating advanced biotechnology with optimized formulation techniques to address cosmetic and therapeutic needs.

How does Carmell Corp ensure product safety and efficacy?

Through extensive testing and research, the company validates its proprietary technology and ensures that its formulations, including the microemulsion system, meet strict standards for safety, efficacy, and quality.